Board Member
Rivian Automotive, Inc. (RIVN)Board Member
Denali Therapeutics Inc. (DNLI)Equibles does not estimate personal net worth.
Get an email with a short summary when Ginkgo Bioworks Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get DNA alertsJay Flatley is recorded as CEO at Ginkgo Bioworks Holdings, Inc. (DNA), Board Member at Rivian Automotive, Inc. (RIVN) since January 1, 2021 and Board Member at Denali Therapeutics Inc. (DNLI) since January 1, 2015. The newest filing on record that lists Jay Flatley as Board Member at Rivian Automotive, Inc. (RIVN) is dated April 27, 2026. The newest filing on record that lists Jay Flatley as Board Member at Denali Therapeutics Inc. (DNLI) is dated April 21, 2026. Jay Flatley has spoken on 2 earnings calls across 1 company, most recently for Ginkgo Bioworks Holdings, Inc. on May 16, 2022. Ginkgo Bioworks Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Denali Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ginkgo Bioworks Holdings, Inc. includes Jason Kelly (CEO and Board Member), Steven Coen (CFO), Reshma Shetty (COO and Board Member) and 7 others.
“Today, I'll provide a brief update on progress against a few of our key programs, and then Ena will also share a more detailed review of our financials, including our preliminary first quarter 2022 results and our forecasted cash runway.”
“On today's call, I will begin with an update on progress across our program pipeline, then review recent developments from our research team and end with a few milestones you can use to monitor our progress.”
2021-01-01–present
Last confirmed April 27, 2026
2015-01-01–present
Last confirmed April 21, 2026
Biotechnology · Healthcare
CEO
Biotechnology · Healthcare
Board Member
2015-01-01–present
Auto Manufacturers · Consumer Cyclical
Board Member
2021-01-01–present
